1. Home
  2. MGLD vs ATYR Comparison

MGLD vs ATYR Comparison

Compare MGLD & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MGLD

The Marygold Companies Inc.

HOLD

Current Price

$1.13

Market Cap

47.0M

Sector

Finance

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.44

Market Cap

46.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGLD
ATYR
Founded
1996
2005
Country
United States
United States
Employees
N/A
58
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.0M
46.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MGLD
ATYR
Price
$1.13
$0.44
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$3.67
AVG Volume (30 Days)
5.3K
2.5M
Earning Date
05-08-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,876,734.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.40
52 Week High
$1.38
$7.29

Technical Indicators

Market Signals
Indicator
MGLD
ATYR
Relative Strength Index (RSI) 55.49 38.96
Support Level $0.89 $0.40
Resistance Level $1.19 $0.86
Average True Range (ATR) 0.05 0.04
MACD 0.00 0.01
Stochastic Oscillator 64.58 8.72

Price Performance

Historical Comparison
MGLD
ATYR

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include U.S. Fund Management through USCF Investments, Food Products via Gourmet Foods and Printstock Products in New Zealand, Beauty Products under the Original Sprout brand, and formerly Security Systems through Brigadier, sold in 2025. The majority of revenue comes from fund management. The company operates in the USA, New Zealand, the United Kingdom, and Canada, with the majority of revenue generated from the USA. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: